vs
Side-by-side financial comparison of Astera Labs, Inc. (ALAB) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.
Astera Labs, Inc. is the larger business by last-quarter revenue ($270.6M vs $220.8M, roughly 1.2× UNIVERSAL TECHNICAL INSTITUTE INC). Astera Labs, Inc. runs the higher net margin — 16.6% vs 5.8%, a 10.8% gap on every dollar of revenue. On growth, Astera Labs, Inc. posted the faster year-over-year revenue change (91.8% vs 9.6%). Astera Labs, Inc. produced more free cash flow last quarter ($76.6M vs $-19.2M). Over the past eight quarters, Astera Labs, Inc.'s revenue compounded faster (103.6% CAGR vs 9.5%).
Astera Labs, Inc. is an American fabless semiconductor manufacturer and artificial intelligence company. The company specializes in designing high-speed connectivity solutions for data centers and AI infrastructure. The company has been listed on the Nasdaq since March 2024.
Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.
ALAB vs UTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $270.6M | $220.8M |
| Net Profit | $45.0M | $12.8M |
| Gross Margin | 75.6% | — |
| Operating Margin | 24.7% | 7.1% |
| Net Margin | 16.6% | 5.8% |
| Revenue YoY | 91.8% | 9.6% |
| Net Profit YoY | 82.0% | -42.1% |
| EPS (diluted) | $0.25 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.6M | $220.8M | ||
| Q3 25 | $230.6M | $222.4M | ||
| Q2 25 | $191.9M | $204.3M | ||
| Q1 25 | $159.4M | $207.4M | ||
| Q4 24 | $141.1M | $201.4M | ||
| Q3 24 | $113.1M | $196.4M | ||
| Q2 24 | $76.8M | $177.5M | ||
| Q1 24 | $65.3M | $184.2M |
| Q4 25 | $45.0M | $12.8M | ||
| Q3 25 | $91.1M | $18.8M | ||
| Q2 25 | $51.2M | $10.7M | ||
| Q1 25 | $31.8M | $11.4M | ||
| Q4 24 | $24.7M | $22.2M | ||
| Q3 24 | $-7.6M | $18.8M | ||
| Q2 24 | $-7.5M | $5.0M | ||
| Q1 24 | $-93.0M | $7.8M |
| Q4 25 | 75.6% | — | ||
| Q3 25 | 76.2% | — | ||
| Q2 25 | 75.8% | — | ||
| Q1 25 | 74.9% | — | ||
| Q4 24 | 74.0% | — | ||
| Q3 24 | 77.7% | — | ||
| Q2 24 | 77.9% | — | ||
| Q1 24 | 77.4% | — |
| Q4 25 | 24.7% | 7.1% | ||
| Q3 25 | 24.0% | 11.2% | ||
| Q2 25 | 20.7% | 6.9% | ||
| Q1 25 | 7.1% | 8.1% | ||
| Q4 24 | 0.1% | 13.6% | ||
| Q3 24 | -7.9% | 13.3% | ||
| Q2 24 | -31.7% | 4.2% | ||
| Q1 24 | -127.1% | 6.1% |
| Q4 25 | 16.6% | 5.8% | ||
| Q3 25 | 39.5% | 8.4% | ||
| Q2 25 | 26.7% | 5.2% | ||
| Q1 25 | 20.0% | 5.5% | ||
| Q4 24 | 17.5% | 11.0% | ||
| Q3 24 | -6.7% | 9.6% | ||
| Q2 24 | -9.8% | 2.8% | ||
| Q1 24 | -142.5% | 4.2% |
| Q4 25 | $0.25 | $0.23 | ||
| Q3 25 | $0.50 | $0.33 | ||
| Q2 25 | $0.29 | $0.19 | ||
| Q1 25 | $0.18 | $0.21 | ||
| Q4 24 | $1.23 | $0.40 | ||
| Q3 24 | $-0.05 | $0.35 | ||
| Q2 24 | $-0.05 | $0.09 | ||
| Q1 24 | $-1.77 | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.6M | $162.8M |
| Total DebtLower is stronger | — | $101.4M |
| Stockholders' EquityBook value | $1.4B | $335.9M |
| Total Assets | $1.5B | $834.0M |
| Debt / EquityLower = less leverage | — | 0.30× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.6M | $162.8M | ||
| Q3 25 | $140.4M | $169.1M | ||
| Q2 25 | $162.3M | $70.7M | ||
| Q1 25 | $86.4M | $96.0M | ||
| Q4 24 | $79.6M | $172.0M | ||
| Q3 24 | $126.1M | $161.9M | ||
| Q2 24 | $421.1M | $115.5M | ||
| Q1 24 | $696.1M | $116.1M |
| Q4 25 | — | $101.4M | ||
| Q3 25 | — | $87.1M | ||
| Q2 25 | — | $73.8M | ||
| Q1 25 | — | $94.4M | ||
| Q4 24 | — | $120.1M | ||
| Q3 24 | — | $125.7M | ||
| Q2 24 | — | $137.3M | ||
| Q1 24 | — | $141.9M |
| Q4 25 | $1.4B | $335.9M | ||
| Q3 25 | $1.3B | $328.1M | ||
| Q2 25 | $1.1B | $306.8M | ||
| Q1 25 | $1.0B | $293.9M | ||
| Q4 24 | $964.8M | $280.0M | ||
| Q3 24 | $889.6M | $260.2M | ||
| Q2 24 | $845.3M | $239.4M | ||
| Q1 24 | $808.8M | $232.6M |
| Q4 25 | $1.5B | $834.0M | ||
| Q3 25 | $1.4B | $826.1M | ||
| Q2 25 | $1.3B | $740.8M | ||
| Q1 25 | $1.1B | $720.4M | ||
| Q4 24 | $1.1B | $753.8M | ||
| Q3 24 | $983.1M | $744.6M | ||
| Q2 24 | $915.5M | $706.0M | ||
| Q1 24 | $864.9M | $702.1M |
| Q4 25 | — | 0.30× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.24× | ||
| Q1 25 | — | 0.32× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 0.48× | ||
| Q2 24 | — | 0.57× | ||
| Q1 24 | — | 0.61× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $95.3M | $3.1M |
| Free Cash FlowOCF − Capex | $76.6M | $-19.2M |
| FCF MarginFCF / Revenue | 28.3% | -8.7% |
| Capex IntensityCapex / Revenue | 6.9% | 10.1% |
| Cash ConversionOCF / Net Profit | 2.12× | 0.24× |
| TTM Free Cash FlowTrailing 4 quarters | $281.8M | $16.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $95.3M | $3.1M | ||
| Q3 25 | $78.2M | $57.1M | ||
| Q2 25 | $135.4M | $18.1M | ||
| Q1 25 | $10.5M | $-789.0K | ||
| Q4 24 | $39.7M | $23.0M | ||
| Q3 24 | $63.5M | $67.5M | ||
| Q2 24 | $29.8M | $10.0M | ||
| Q1 24 | $3.7M | $-2.5M |
| Q4 25 | $76.6M | $-19.2M | ||
| Q3 25 | $65.9M | $40.6M | ||
| Q2 25 | $133.3M | $6.8M | ||
| Q1 25 | $6.0M | $-11.7M | ||
| Q4 24 | $24.3M | $19.6M | ||
| Q3 24 | $46.8M | $60.0M | ||
| Q2 24 | $28.5M | $3.0M | ||
| Q1 24 | $228.0K | $-8.4M |
| Q4 25 | 28.3% | -8.7% | ||
| Q3 25 | 28.6% | 18.3% | ||
| Q2 25 | 69.5% | 3.4% | ||
| Q1 25 | 3.7% | -5.7% | ||
| Q4 24 | 17.2% | 9.7% | ||
| Q3 24 | 41.4% | 30.6% | ||
| Q2 24 | 37.1% | 1.7% | ||
| Q1 24 | 0.3% | -4.6% |
| Q4 25 | 6.9% | 10.1% | ||
| Q3 25 | 5.3% | 7.4% | ||
| Q2 25 | 1.1% | 5.5% | ||
| Q1 25 | 2.8% | 5.3% | ||
| Q4 24 | 10.9% | 1.7% | ||
| Q3 24 | 14.8% | 3.8% | ||
| Q2 24 | 1.7% | 4.0% | ||
| Q1 24 | 5.2% | 3.2% |
| Q4 25 | 2.12× | 0.24× | ||
| Q3 25 | 0.86× | 3.04× | ||
| Q2 25 | 2.64× | 1.69× | ||
| Q1 25 | 0.33× | -0.07× | ||
| Q4 24 | 1.61× | 1.04× | ||
| Q3 24 | — | 3.58× | ||
| Q2 24 | — | 2.01× | ||
| Q1 24 | — | -0.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALAB
Segment breakdown not available.
UTI
| UTI | $142.8M | 65% |
| Concorde | $78.0M | 35% |
